Drug discovery is by definition slow and costly. The multiphase process, which begins with basic science research and ends with clinical trials, can consume up to two decades and more than a billion dollars.
Northeastern University chemistry and chemical biology professor Michael Pollastri believes an open-source science model will hasten the drug discovery process. Despite great advances in NTD research over the last decade, the global research effort is largely uncoordinated.
“We’re wasting resources in a very resource-poor area,” says Pollastri, who spent nine years in the pharmaceutical industry before transitioning to academia. “There is a range of data sharing scenarios,” he says.